Anne Panhelainen

Anne Panhelainen is a Clinical Process Manager at Sooma Medical, a position held since July 2021. Panhelainen has an extensive research background, with contributions to the field since May 2005 and experience as a researcher and lecturer at the University of Helsinki from 2006 to 2021, including roles at the Institute of Biotechnology and the Department of Pharmacology and Pharmacotherapy. Panhelainen's research work includes significant publications, notably on neuronal dopamine homeostasis, demonstrated in the article "Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure," published in the Journal of Biological Chemistry in 2015. Educational credentials include a Doctor of Philosophy in Neuropharmacology and a Master of Science in Physiology, Pharmacology, Toxicology, Biochemistry, and Cell Biology, both earned at the University of Helsinki.